5-Methylbenzimidazole - CAS 614-97-1
Catalog: |
BB031146 |
Product Name: |
5-Methylbenzimidazole |
CAS: |
614-97-1 |
Synonyms: |
6-methyl-1H-benzimidazole; 6-methyl-1H-benzimidazole |
IUPAC Name: | 6-methyl-1H-benzimidazole |
Description: | 5-Methylbenzimidazole (CAS# 614-97-1) is a useful research chemical. |
Molecular Weight: | 132.16 |
Molecular Formula: | C8H8N2 |
Canonical SMILES: | CC1=CC2=C(C=C1)N=CN2 |
InChI: | InChI=1S/C8H8N2/c1-6-2-3-7-8(4-6)10-5-9-7/h2-5H,1H3,(H,9,10) |
InChI Key: | RWXZXCZBMQPOBF-UHFFFAOYSA-N |
Boiling Point: | 169-172 °C (1 mmHg) |
Melting Point: | 114-117 °C |
Density: | 1.186 g/cm3 |
MDL: | MFCD00010740 |
LogP: | 1.87130 |
GHS Hazard Statement: | H302 (42.86%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P340, P305+P351+P338, P312, P321, P330, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2021120890-A1 | Pyrazolyl derivatives useful as anti-cancer agents | 20191220 |
WO-2021122745-A1 | 4-[[(7-aminopyrazolo[1,5-a]pyrimidin-5-yl)amino]methyl]piperidin-3-ol compounds and their therapeutic use | 20191216 |
WO-2021115489-A1 | Novel heterocyclic derivatives with cardiomyocyte proliferation activity for treatment of heart diseases | 20191214 |
WO-2021110076-A1 | Oxamide derivatives, preparation method therefor and use thereof in medicine | 20191204 |
WO-2021108803-A1 | Fused pyrimidine pyridinone compounds as jak inhibitors | 20191126 |
PMID | Publication Date | Title | Journal |
21297296 | 20110101 | Effect of substitution on the antimycobacterial activity of 2-(substituted benzyl)sulfanyl benzimidazoles, benzoxazoles, and benzothiazoles--a quantitative structure-activity relationship study | Chemical & pharmaceutical bulletin |
20395166 | 20100701 | Molecular structure and vibrational spectra of 2- and 5-methylbenzimidazole molecules by density functional theory | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy |
21583121 | 20090514 | 2-Meth-oxy-6-(6-methyl-1H-benzimidazol-2-yl)phenol | Acta crystallographica. Section E, Structure reports online |
17379526 | 20070515 | The screening and characterization of 6-aminopurine-based xanthine oxidase inhibitors | Bioorganic & medicinal chemistry |
15962942 | 20050601 | Prediction of genotoxicity of chemical compounds by statistical learning methods | Chemical research in toxicology |
Complexity: | 124 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 132.068748264 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 132.068748264 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 28.7 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.7 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Benzimidazoles
Customers Also Viewed
-
[57166-92-4]
Methylenediamine dihydrochloride
-
[75726-96-4]
2-Bromo-N-isopropylacetamide
-
[891016-02-7]
ML-SI3
-
[119-24-4]
Folic Acid EP Impurity D (Methotrexate EP Impurity D)
-
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
-
[35045-02-4]
Metribuzin-desamino
INDUSTRY LEADERS TRUST OUR PRODUCTS